Page 1 of 1

Following Trumps inauguration

Posted: Thu Jan 23, 2025 10:41 am
by s.inf.o2.6.9
These critics have advocated for a return to a more restrained antitrust framework similar to the one that prevailed in the U.S. for decades. Despite this opposition it is widely believed that President-elect Donald Trumps antitrust appointees are unlikely to significantly scale back enforcement efforts in the immediate future. Gail Slater an aide to incoming Vice President JD Vance is expected to succeed Kanter pending confirmation. Vance before being tapped as Trumps running mate praised Khans leadership and echoed concerns about corporate overreach calling some corporate behavior tyrannical. Until Vance assumes office Kanters deputy Doha Mekki will serve as the acting head of the antitrust division.

it remains to be seen whether a new bolivia whatsapp number database appointment will shift the direction of the division. During his tenure Kanter revitalized the DOJs antitrust agenda bringing several high-profile cases against major companies such as Apple Google Visa and Ticketmaster. His office also secured a major legal win against Google in a case over its dominance in online search. Kanters division also successfully blocked notable corporate mergers including JetBlues proposed tie-up with American Airlines Spirit Airlines merger with JetBlue and the $ billion merger between Penguin Random House and Simon & Schuster. Source: Reuters Sandoz Settles Price-Fixing Allegations with $ Million Agreement By CPI | December Sandoz and its subsidiary Fougera Pharmaceuticals have agreed to a $ million settlement to resolve claims tied to long-standing price-fixing litigation marking a significant step for the company as it works to move beyond past legal challenges.

According to a statement released by Sandoz the settlement involves a class of end-payer plaintiffs who alleged anticompetitive practices took place between and The agreement however includes no admission of wrongdoing as stated by the company. The group of end-payer plaintiffs in this multi-district litigation comprises various entities including consumers health insurers employee benefit plans and welfare funds that incurred costs related to the purchase or reimbursement of drug sales during the disputed period. Read more: Independent Pharmacies Seek Court Unification in Fight Over Generic Drug Payments Sandoz inherited the legal battle from its former parent company Novartis. In recent years Sandoz has been actively working to resolve these legacy allegations and the latest settlement marks progress toward closing this chapter.